Employees: 1-10
Mentions in press and media 14
| Date | Title | Description |
| 25.06.2024 | Juniper Biologics Revolutionizes Cancer Care in MEA Through Partnership with Caris Life Sciences | In a groundbreaking move, Juniper Biologics, a prominent player in the healthcare and pharmaceutical industry, has expanded its distribution rights for Caris Life Sciences' solid tumour molecular profiling services in the Middle East and Af... |
| 24.06.2024 | Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Molecular Profiling in the Middle East and Africa | SINGAPORE, June 24, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Cari... |
| 23.06.2024 | Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Molecular Profiling in the Middle East and Africa | SINGAPORE, June 23, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Cari... |
| 22.04.2024 | Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards | SINGAPORE, April 22, 2024 /PRNewswire/ -- Juniper Biologics ("Juniper"), a global science-led pharmaceutical company dedicated to advancing treatments in specialised therapy areas, has been named "Pharmaceutical Company of th... |
| 25.03.2024 | Advancing Healthcare Innovation: Juniper Biologics Recognized as the Best Novel Therapy R&D and Commercialization Company 2024 by APAC Insider | SINGAPORE, March 25, 2024 /PRNewswire/ -- Juniper Biologics ("Juniper"), Singapore-based science-led pharmaceutical company focused on researching, developing, and commercializing novel therapies, celebrates another milestone as i... |
| 08.01.2024 | Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023 | SINGAPORE, Jan. 8, 2024 /PRNewswire/ -- Juniper Biologics ("Juniper"), a global science-led pharmaceutical company headquartered in Singapore, proudly announces its latest achievement, winning the award for Molecular Science &... |
| 24.10.2023 | Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards | SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics, a global science-led pharmaceutical company headquartered in Singapore, has been honored with the prestigious title of the "Most Innovative Oncology Pharmaceutical Company 202... |
| 12.01.2023 | JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA | SINGAPORE, Jan. 11, 2023 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd, a science-led healthcare company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences® (Caris)' ... |
| 12.01.2023 | JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA | SINGAPORE, Jan. 12, 2023 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd, a science-led healthcare company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences® (Caris)' ... |
| 23.12.2022 | JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL | Best Cell & Gene Therapy Acquisition 2022: Juniper Biologics/Kolon Life Science SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd, a science-led healthcare company focused on commercialising nove... |
Show more